These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15714964)

  • 1. [Mechanism of prostate cancer development].
    Tsuchiya N; Habuchi T
    Nihon Rinsho; 2005 Feb; 63(2):194-7. PubMed ID: 15714964
    [No Abstract]   [Full Text] [Related]  

  • 2. [New biomarkers for prostate cancer].
    Suzuki H; Shimbo M; Ichikawa T
    Nihon Rinsho; 2005 Feb; 63(2):351-9. PubMed ID: 15714991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polymorphisms of hormone-related genes and prostate cancer risk in Japan].
    Watanabe M; Hirokawa Y; Shiraishi T
    Nihon Rinsho; 2005 Feb; 63(2):219-24. PubMed ID: 15714969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium.
    Huang J; Powell WC; Khodavirdi AC; Wu J; Makita T; Cardiff RD; Cohen MB; Sucov HM; Roy-Burman P
    Cancer Res; 2002 Aug; 62(16):4812-9. PubMed ID: 12183441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prospects of genetic polymorphism analyses in prostatic disease].
    Kagawa S; Nishitani MA
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():474-8. PubMed ID: 12599622
    [No Abstract]   [Full Text] [Related]  

  • 6. Chromosome mechanisms giving rise to the TMPRSS2-ERG fusion oncogene in prostate cancer and HGPIN lesions.
    Teixeira MR
    Am J Surg Pathol; 2008 Apr; 32(4):642-4; author reply 644. PubMed ID: 18317354
    [No Abstract]   [Full Text] [Related]  

  • 7. Steroid hormones and hormone-related genetic and lifestyle characteristics as risk factors for benign prostatic hyperplasia: review of epidemiologic literature.
    Neuhouser ML; Kristal AR; Penson DF
    Urology; 2004 Aug; 64(2):201-11. PubMed ID: 15302461
    [No Abstract]   [Full Text] [Related]  

  • 8. Alterations of androgen receptor in prostate cancer.
    Linja MJ; Visakorpi T
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):255-64. PubMed ID: 15663988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor expression in prostatic intraepithelial neoplasia and cancer.
    Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Bostwick DG
    J Urol; 1999 Apr; 161(4):1229-32. PubMed ID: 10081875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and role of Foxa proteins in prostate cancer.
    Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ
    Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
    Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
    Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenic factor gene dosage abnormalities in prostatic intraepithelial neoplasia and prostate cancer.
    Doak SH; Jenkins SA; Hurle RA; Varma M; Hawizy A; Kynaston HG; Parry JM
    Cancer Genet Cytogenet; 2007 Jul; 176(2):161-5. PubMed ID: 17656261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Androgens and androgen receptor in prostate cancer].
    Miyoshi Y; Kubota Y
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():489-93. PubMed ID: 16689355
    [No Abstract]   [Full Text] [Related]  

  • 14. Amplification and co-regulators of androgen receptor gene in prostate cancer.
    Golias Ch; Iliadis I; Peschos D; Charalabopoulos K
    Exp Oncol; 2009 Mar; 31(1):3-8. PubMed ID: 19300409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative analysis of genomic aberrations associated with prostate cancer progression.
    Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
    Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular and endocrinological mechanism of benign prostatic hyperplasia and prostate cancer].
    Kinoshita H; Habuchi T; Ogawa O
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():23-7. PubMed ID: 12599539
    [No Abstract]   [Full Text] [Related]  

  • 17. [Mechanisms of prostate cancer recurrence].
    Mizokami A; Namiki M
    Hinyokika Kiyo; 2002 Nov; 48(11):709-11. PubMed ID: 12512146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ETS gene aberrations in atypical cribriform lesions of the prostate: Implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia.
    Han B; Suleman K; Wang L; Siddiqui J; Sercia L; Magi-Galluzzi C; Palanisamy N; Chinnaiyan AM; Zhou M; Shah RB
    Am J Surg Pathol; 2010 Apr; 34(4):478-85. PubMed ID: 20220513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor and vitamin D receptor gene polymorphisms and prostate cancer risk.
    Andersson P; Varenhorst E; Söderkvist P
    Eur J Cancer; 2006 Nov; 42(16):2833-7. PubMed ID: 17010601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors.
    Tsujimoto Y; Takakuwa T; Takayama H; Nishimura K; Okuyama A; Aozasa K; Nonomura N
    Prostate; 2004 Feb; 58(3):283-90. PubMed ID: 14743468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.